Document is current
Any future updates will be listed below
-
Authors
Kousa, Anastasia I. https://orcid.org/0000-0002-4550-0389
Jahn, Lorenz https://orcid.org/0000-0002-9880-7026
Zhao, Kelin
Flores, Angel E.
Acenas, Dante II
Lederer, Emma https://orcid.org/0009-0008-4103-5388
Argyropoulos, Kimon V.
Lemarquis, Andri L.
Granadier, David
Cooper, Kirsten https://orcid.org/0000-0002-0711-2713
D’Andrea, Michael https://orcid.org/0000-0002-2557-3628
Sheridan, Julie M. https://orcid.org/0000-0002-1478-3662
Tsai, Jennifer https://orcid.org/0000-0002-9267-4584
Sikkema, Lisa
Lazrak, Amina
Nichols, Katherine
Lee, Nichole
Ghale, Romina
Malard, Florent
Andrlova, Hana
Velardi, Enrico https://orcid.org/0000-0001-8383-0453
Youssef, Salma https://orcid.org/0009-0005-3499-7755
Burgos da Silva, Marina
Docampo, Melissa
Sharma, Roshan
Mazutis, Linas https://orcid.org/0000-0002-5552-6427
Wimmer, Verena C.
Rogers, Kelly L. https://orcid.org/0000-0002-6755-0221
DeWolf, Susan
Gipson, Brianna https://orcid.org/0009-0005-5837-8676
Gomes, Antonio L. C.
Setty, Manu https://orcid.org/0000-0002-0344-2627
Pe’er, Dana https://orcid.org/0000-0002-9259-8817
Hale, Laura
Manley, Nancy R.
Gray, Daniel H. D. https://orcid.org/0000-0002-8457-8242
van den Brink, Marcel R. M. https://orcid.org/0000-0003-0696-4401
Dudakov, Jarrod A. https://orcid.org/0000-0001-6220-5632
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R35-HL-171556, R01-HL145276, R01-HL165673, F30-HL165761, R01-HL123340, R01-HL147584)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U01-AI70035)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30-CA015704, R01-CA228308, P30 CA008748)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (P01-AG052359)
European Molecular Biology Organization (ALTF-431-2017)
Department of Health | National Health and Medical Research Council (1090236, 1158024, 1078763, 1121325, 1187367)
Cancer Council Victoria (1146518, 1102104)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32-GM007270)
- License Information
-
More Information
Article History
Received: 26 May 2023
Accepted: 3 July 2024
First Online: 7 August 2024
Competing interests
: M.R.M.vdB. has received research support and stock options from Seres Therapeutics and stock options from Notch Therapeutics and Pluto Therapeutics; has consulted, received honorarium from or participated in advisory boards for Seres Therapeutics, WindMIL Therapeutics, Rheos Medicines, Merck & Co, Magenta Therapeutics, Frazier Healthcare Partners, Nektar Therapeutics, Notch Therapeutics, Forty Seven, Priothera, Ceramedix, Lygenesis, Pluto Therapeutics, GlaskoSmithKline, Da Volterra, Vor BioPharma, Novartis (Spouse), Synthekine (Spouse) and Beigene (Spouse); he has IP Licensing with Seres Therapeutics and Juno Therapeutics; and holds a fiduciary role on the Foundation Board of DKMS (a nonprofit organization). J.A.D. and M.R.M.vdB. are founders of, and receive stock options, from ThymoFox; and both have received royalties from Wolters Kluwer. The Walter and Eliza Hall Institute of Medical Research receives milestone and royalty payments related to venetoclax. Employees are entitled to receive benefits related to these payments; D.H.D.G. reports receiving benefits. D.H.D.G. has received research funding from Servier. The remaining authors declare no competing interests.
